drugset
drugset / Trial / NCT04522674

Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine

NCT04522674 ↗

Phase 0 Completed 5 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the feasibility of standardized autologous platelet rich plasma injections into osteoarthritic lumbar facet joints to treat back pain and improve patient function.

Timeline

Start
2021-02-19
Primary completion
2022-04-28
Completion
2022-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 0.5 ml Other

Indications

No indication recorded.